Global Non-opioid Analgesic Patch Market Growth 2025-2031

Product Code: 1694022

Industry: Pharma & Healthcare

Published: Jul 12,2025

Pages: 153

Delivery Time: 2-3 business days

Global Non-opioid Analgesic Patch Market Growth 2025-2031

Product Code: 1694022

Industry: Pharma & Healthcare

Published: Jul 12,2025

Pages: 153

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Non-opioid Analgesic Patch market size is predicted to grow from US$ 3475 million in 2025 to US$ 4556 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

A non-opioid analgesic patch is a transdermal delivery system that administers pain-relieving medication directly through the skin without using opioids. It typically contains non-narcotic agents such as non-steroidal anti-inflammatory drugs (NSAIDs) or other alternative analgesics, which provide targeted, sustained relief for localized pain conditions. By releasing the active ingredient steadily over several hours, these patches help maintain consistent therapeutic levels at the site of pain, reducing the need for frequent dosing and minimizing systemic side effects. This method of pain management offers an effective and safer alternative to opioid-based treatments, lowering the risk of dependency and adverse reactions while improving patient compliance and comfort.

The global Non-opioid Analgesic Patch market is experiencing steady growth, driven by the increasing demand for safer and non-addictive pain management solutions. Rising awareness of the risks associated with opioid medications, particularly the opioid crisis in North America, has accelerated the shift toward alternative pain relief options. These patches, typically containing NSAIDs (e.g., diclofenac or ketoprofen), lidocaine, or herbal actives, are gaining popularity due to their targeted delivery, minimal systemic exposure, and ease of use.

In terms of market structure, the global non-opioid analgesic patch market is dominated by a few multinational pharmaceutical companies along with several regional players. Hisamitsu Pharmaceutical of Japan is a benchmark enterprise globally for transdermal analgesic products, while Lead Chemical and Teikoku Seiyaku hold core competitiveness in patch manufacturing and international supply. In Europe and North America, the market is led by brands such as Haleon, IBSA, Grünenthal (Averitas), and Kenvue, along with generic drug manufacturers like Teva and Viatris. In China, domestic companies such as Lingrui Pharmaceutical, Yunnan Baiyao, Jiudian Pharmaceutical, and Tide Pharmaceutical have secured certain market shares through broad distribution networks and inclusion in national reimbursement lists. Going forward, as non-opioid pain management policies evolve and transdermal technologies continue to advance, the global market is expected to see further consolidation.

LP Information, Inc. (LPI) ' newest research report, the “Non-opioid Analgesic Patch Industry Forecast” looks at past sales and reviews total world Non-opioid Analgesic Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-opioid Analgesic Patch sales for 2025 through 2031. With Non-opioid Analgesic Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Analgesic Patch industry.

This Insight Report provides a comprehensive analysis of the global Non-opioid Analgesic Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Analgesic Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Analgesic Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Analgesic Patch and breaks down the forecast by Product, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Analgesic Patch.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Analgesic Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by Product:
    Lidocaine Patch
    Diclofenac Patch
    Methyl Salicylate Patch
    Flurbiprofen Patch
    Loxoprofen Sodium Patch
    Ketoprofen Patch
    Capsaicin Patch
    Others

Segmentation by Application:
    Hospitals and Clinics
    Retail Pharmacy
    Online Pharmacy

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    Hisamitsu Pharmaceutical
    Teikoku Seiyaku
    IBSA Pharma
    Kowa Company
    Haleon
    Kenvue
    Opella Healthcare
    Viatris
    Teva Pharmaceuticals
    Lead Chemical
    Mikasa Seiyaku
    Averitas Pharma
    Sparsha Pharma
    TEH SENG Pharmaceutical
    Anhui Fengyuan Pharmaceutical
    Beijing Tide Pharmaceutical
    Jiudian Pharmaceutical
    Yunnan Baiyao
    Lingrui Pharmaceutical
    Anhui Jinma Pharmaceutical
    Guizhou Liansheng Pharmaceutical

Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-opioid Analgesic Patch market?
What factors are driving Non-opioid Analgesic Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Analgesic Patch market opportunities vary by end market size?
How does Non-opioid Analgesic Patch break out by Product, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Non-opioid Analgesic Patch Annual Sales 2020-2031
        2.1.2 World Current & Future Analysis for Non-opioid Analgesic Patch by Geographic Region, 2020, 2024 & 2031
        2.1.3 World Current & Future Analysis for Non-opioid Analgesic Patch by Country/Region, 2020, 2024 & 2031
    2.2 Non-opioid Analgesic Patch Segment by Product
        2.2.1 Lidocaine Patch
        2.2.2 Diclofenac Patch
        2.2.3 Methyl Salicylate Patch
        2.2.4 Flurbiprofen Patch
        2.2.5 Loxoprofen Sodium Patch
        2.2.6 Ketoprofen Patch
        2.2.7 Capsaicin Patch
        2.2.8 Others
    2.3 Non-opioid Analgesic Patch Sales by Product
        2.3.1 Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
        2.3.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Product (2020-2025)
        2.3.3 Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025)
    2.4 Non-opioid Analgesic Patch Segment by Application
        2.4.1 Hospitals and Clinics
        2.4.2 Retail Pharmacy
        2.4.3 Online Pharmacy
    2.5 Non-opioid Analgesic Patch Sales by Application
        2.5.1 Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
        2.5.2 Global Non-opioid Analgesic Patch Revenue and Market Share by Application (2020-2025)
        2.5.3 Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025)

3 Global by Company
    3.1 Global Non-opioid Analgesic Patch Breakdown Data by Company
        3.1.1 Global Non-opioid Analgesic Patch Annual Sales by Company (2020-2025)
        3.1.2 Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
    3.2 Global Non-opioid Analgesic Patch Annual Revenue by Company (2020-2025)
        3.2.1 Global Non-opioid Analgesic Patch Revenue by Company (2020-2025)
        3.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
    3.3 Global Non-opioid Analgesic Patch Sale Price by Company
    3.4 Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Non-opioid Analgesic Patch Product Location Distribution
        3.4.2 Players Non-opioid Analgesic Patch Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Non-opioid Analgesic Patch by Geographic Region
    4.1 World Historic Non-opioid Analgesic Patch Market Size by Geographic Region (2020-2025)
        4.1.1 Global Non-opioid Analgesic Patch Annual Sales by Geographic Region (2020-2025)
        4.1.2 Global Non-opioid Analgesic Patch Annual Revenue by Geographic Region (2020-2025)
    4.2 World Historic Non-opioid Analgesic Patch Market Size by Country/Region (2020-2025)
        4.2.1 Global Non-opioid Analgesic Patch Annual Sales by Country/Region (2020-2025)
        4.2.2 Global Non-opioid Analgesic Patch Annual Revenue by Country/Region (2020-2025)
    4.3 Americas Non-opioid Analgesic Patch Sales Growth
    4.4 APAC Non-opioid Analgesic Patch Sales Growth
    4.5 Europe Non-opioid Analgesic Patch Sales Growth
    4.6 Middle East & Africa Non-opioid Analgesic Patch Sales Growth

5 Americas
    5.1 Americas Non-opioid Analgesic Patch Sales by Country
        5.1.1 Americas Non-opioid Analgesic Patch Sales by Country (2020-2025)
        5.1.2 Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025)
    5.2 Americas Non-opioid Analgesic Patch Sales by Product (2020-2025)
    5.3 Americas Non-opioid Analgesic Patch Sales by Application (2020-2025)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Non-opioid Analgesic Patch Sales by Region
        6.1.1 APAC Non-opioid Analgesic Patch Sales by Region (2020-2025)
        6.1.2 APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025)
    6.2 APAC Non-opioid Analgesic Patch Sales by Product (2020-2025)
    6.3 APAC Non-opioid Analgesic Patch Sales by Application (2020-2025)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Non-opioid Analgesic Patch by Country
        7.1.1 Europe Non-opioid Analgesic Patch Sales by Country (2020-2025)
        7.1.2 Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025)
    7.2 Europe Non-opioid Analgesic Patch Sales by Product (2020-2025)
    7.3 Europe Non-opioid Analgesic Patch Sales by Application (2020-2025)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Non-opioid Analgesic Patch by Country
        8.1.1 Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025)
        8.1.2 Middle East & Africa Non-opioid Analgesic Patch Revenue by Country (2020-2025)
    8.2 Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025)
    8.3 Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch
    10.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
    10.4 Industry Chain Structure of Non-opioid Analgesic Patch

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Non-opioid Analgesic Patch Distributors
    11.3 Non-opioid Analgesic Patch Customer

12 World Forecast Review for Non-opioid Analgesic Patch by Geographic Region
    12.1 Global Non-opioid Analgesic Patch Market Size Forecast by Region
        12.1.1 Global Non-opioid Analgesic Patch Forecast by Region (2026-2031)
        12.1.2 Global Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031)
    12.2 Americas Forecast by Country (2026-2031)
    12.3 APAC Forecast by Region (2026-2031)
    12.4 Europe Forecast by Country (2026-2031)
    12.5 Middle East & Africa Forecast by Country (2026-2031)
    12.6 Global Non-opioid Analgesic Patch Forecast by Product (2026-2031)
    12.7 Global Non-opioid Analgesic Patch Forecast by Application (2026-2031)

13 Key Players Analysis
    13.1 Hisamitsu Pharmaceutical
        13.1.1 Hisamitsu Pharmaceutical Company Information
        13.1.2 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.1.3 Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.1.4 Hisamitsu Pharmaceutical Main Business Overview
        13.1.5 Hisamitsu Pharmaceutical Latest Developments
    13.2 Teikoku Seiyaku
        13.2.1 Teikoku Seiyaku Company Information
        13.2.2 Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.2.3 Teikoku Seiyaku Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.2.4 Teikoku Seiyaku Main Business Overview
        13.2.5 Teikoku Seiyaku Latest Developments
    13.3 IBSA Pharma
        13.3.1 IBSA Pharma Company Information
        13.3.2 IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.3.3 IBSA Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.3.4 IBSA Pharma Main Business Overview
        13.3.5 IBSA Pharma Latest Developments
    13.4 Kowa Company
        13.4.1 Kowa Company Company Information
        13.4.2 Kowa Company Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.4.3 Kowa Company Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.4.4 Kowa Company Main Business Overview
        13.4.5 Kowa Company Latest Developments
    13.5 Haleon
        13.5.1 Haleon Company Information
        13.5.2 Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.5.3 Haleon Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.5.4 Haleon Main Business Overview
        13.5.5 Haleon Latest Developments
    13.6 Kenvue
        13.6.1 Kenvue Company Information
        13.6.2 Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.6.3 Kenvue Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.6.4 Kenvue Main Business Overview
        13.6.5 Kenvue Latest Developments
    13.7 Opella Healthcare
        13.7.1 Opella Healthcare Company Information
        13.7.2 Opella Healthcare Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.7.3 Opella Healthcare Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.7.4 Opella Healthcare Main Business Overview
        13.7.5 Opella Healthcare Latest Developments
    13.8 Viatris
        13.8.1 Viatris Company Information
        13.8.2 Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.8.3 Viatris Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.8.4 Viatris Main Business Overview
        13.8.5 Viatris Latest Developments
    13.9 Teva Pharmaceuticals
        13.9.1 Teva Pharmaceuticals Company Information
        13.9.2 Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.9.3 Teva Pharmaceuticals Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.9.4 Teva Pharmaceuticals Main Business Overview
        13.9.5 Teva Pharmaceuticals Latest Developments
    13.10 Lead Chemical
        13.10.1 Lead Chemical Company Information
        13.10.2 Lead Chemical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.10.3 Lead Chemical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.10.4 Lead Chemical Main Business Overview
        13.10.5 Lead Chemical Latest Developments
    13.11 Mikasa Seiyaku
        13.11.1 Mikasa Seiyaku Company Information
        13.11.2 Mikasa Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.11.3 Mikasa Seiyaku Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.11.4 Mikasa Seiyaku Main Business Overview
        13.11.5 Mikasa Seiyaku Latest Developments
    13.12 Averitas Pharma
        13.12.1 Averitas Pharma Company Information
        13.12.2 Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.12.3 Averitas Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.12.4 Averitas Pharma Main Business Overview
        13.12.5 Averitas Pharma Latest Developments
    13.13 Sparsha Pharma
        13.13.1 Sparsha Pharma Company Information
        13.13.2 Sparsha Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.13.3 Sparsha Pharma Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.13.4 Sparsha Pharma Main Business Overview
        13.13.5 Sparsha Pharma Latest Developments
    13.14 TEH SENG Pharmaceutical
        13.14.1 TEH SENG Pharmaceutical Company Information
        13.14.2 TEH SENG Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.14.3 TEH SENG Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.14.4 TEH SENG Pharmaceutical Main Business Overview
        13.14.5 TEH SENG Pharmaceutical Latest Developments
    13.15 Anhui Fengyuan Pharmaceutical
        13.15.1 Anhui Fengyuan Pharmaceutical Company Information
        13.15.2 Anhui Fengyuan Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.15.3 Anhui Fengyuan Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.15.4 Anhui Fengyuan Pharmaceutical Main Business Overview
        13.15.5 Anhui Fengyuan Pharmaceutical Latest Developments
    13.16 Beijing Tide Pharmaceutical
        13.16.1 Beijing Tide Pharmaceutical Company Information
        13.16.2 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.16.3 Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.16.4 Beijing Tide Pharmaceutical Main Business Overview
        13.16.5 Beijing Tide Pharmaceutical Latest Developments
    13.17 Jiudian Pharmaceutical
        13.17.1 Jiudian Pharmaceutical Company Information
        13.17.2 Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.17.3 Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.17.4 Jiudian Pharmaceutical Main Business Overview
        13.17.5 Jiudian Pharmaceutical Latest Developments
    13.18 Yunnan Baiyao
        13.18.1 Yunnan Baiyao Company Information
        13.18.2 Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.18.3 Yunnan Baiyao Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.18.4 Yunnan Baiyao Main Business Overview
        13.18.5 Yunnan Baiyao Latest Developments
    13.19 Lingrui Pharmaceutical
        13.19.1 Lingrui Pharmaceutical Company Information
        13.19.2 Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.19.3 Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.19.4 Lingrui Pharmaceutical Main Business Overview
        13.19.5 Lingrui Pharmaceutical Latest Developments
    13.20 Anhui Jinma Pharmaceutical
        13.20.1 Anhui Jinma Pharmaceutical Company Information
        13.20.2 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.20.3 Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.20.4 Anhui Jinma Pharmaceutical Main Business Overview
        13.20.5 Anhui Jinma Pharmaceutical Latest Developments
    13.21 Guizhou Liansheng Pharmaceutical
        13.21.1 Guizhou Liansheng Pharmaceutical Company Information
        13.21.2 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
        13.21.3 Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2020-2025)
        13.21.4 Guizhou Liansheng Pharmaceutical Main Business Overview
        13.21.5 Guizhou Liansheng Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Non-opioid Analgesic Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Table 2. Non-opioid Analgesic Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
 Table 3. Major Players of Lidocaine Patch
 Table 4. Major Players of Diclofenac Patch
 Table 5. Major Players of Methyl Salicylate Patch
 Table 6. Major Players of Flurbiprofen Patch
 Table 7. Major Players of Loxoprofen Sodium Patch
 Table 8. Major Players of Ketoprofen Patch
 Table 9. Major Players of Capsaicin Patch
 Table 10. Major Players of Others
 Table 11. Global Non-opioid Analgesic Patch Sales by Product (2020-2025) & (M Pcs)
 Table 12. Global Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
 Table 13. Global Non-opioid Analgesic Patch Revenue by Product (2020-2025) & ($ million)
 Table 14. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
 Table 15. Global Non-opioid Analgesic Patch Sale Price by Product (2020-2025) & (US$/Pcs)
 Table 16. Global Non-opioid Analgesic Patch Sale by Application (2020-2025) & (M Pcs)
 Table 17. Global Non-opioid Analgesic Patch Sale Market Share by Application (2020-2025)
 Table 18. Global Non-opioid Analgesic Patch Revenue by Application (2020-2025) & ($ million)
 Table 19. Global Non-opioid Analgesic Patch Revenue Market Share by Application (2020-2025)
 Table 20. Global Non-opioid Analgesic Patch Sale Price by Application (2020-2025) & (US$/Pcs)
 Table 21. Global Non-opioid Analgesic Patch Sales by Company (2020-2025) & (M Pcs)
 Table 22. Global Non-opioid Analgesic Patch Sales Market Share by Company (2020-2025)
 Table 23. Global Non-opioid Analgesic Patch Revenue by Company (2020-2025) & ($ millions)
 Table 24. Global Non-opioid Analgesic Patch Revenue Market Share by Company (2020-2025)
 Table 25. Global Non-opioid Analgesic Patch Sale Price by Company (2020-2025) & (US$/Pcs)
 Table 26. Key Manufacturers Non-opioid Analgesic Patch Producing Area Distribution and Sales Area
 Table 27. Players Non-opioid Analgesic Patch Products Offered
 Table 28. Non-opioid Analgesic Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
 Table 29. New Products and Potential Entrants
 Table 30. Market M&A Activity & Strategy
 Table 31. Global Non-opioid Analgesic Patch Sales by Geographic Region (2020-2025) & (M Pcs)
 Table 32. Global Non-opioid Analgesic Patch Sales Market Share Geographic Region (2020-2025)
 Table 33. Global Non-opioid Analgesic Patch Revenue by Geographic Region (2020-2025) & ($ millions)
 Table 34. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region (2020-2025)
 Table 35. Global Non-opioid Analgesic Patch Sales by Country/Region (2020-2025) & (M Pcs)
 Table 36. Global Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020-2025)
 Table 37. Global Non-opioid Analgesic Patch Revenue by Country/Region (2020-2025) & ($ millions)
 Table 38. Global Non-opioid Analgesic Patch Revenue Market Share by Country/Region (2020-2025)
 Table 39. Americas Non-opioid Analgesic Patch Sales by Country (2020-2025) & (M Pcs)
 Table 40. Americas Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
 Table 41. Americas Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
 Table 42. Americas Non-opioid Analgesic Patch Sales by Product (2020-2025) & (M Pcs)
 Table 43. Americas Non-opioid Analgesic Patch Sales by Application (2020-2025) & (M Pcs)
 Table 44. APAC Non-opioid Analgesic Patch Sales by Region (2020-2025) & (M Pcs)
 Table 45. APAC Non-opioid Analgesic Patch Sales Market Share by Region (2020-2025)
 Table 46. APAC Non-opioid Analgesic Patch Revenue by Region (2020-2025) & ($ millions)
 Table 47. APAC Non-opioid Analgesic Patch Sales by Product (2020-2025) & (M Pcs)
 Table 48. APAC Non-opioid Analgesic Patch Sales by Application (2020-2025) & (M Pcs)
 Table 49. Europe Non-opioid Analgesic Patch Sales by Country (2020-2025) & (M Pcs)
 Table 50. Europe Non-opioid Analgesic Patch Revenue by Country (2020-2025) & ($ millions)
 Table 51. Europe Non-opioid Analgesic Patch Sales by Product (2020-2025) & (M Pcs)
 Table 52. Europe Non-opioid Analgesic Patch Sales by Application (2020-2025) & (M Pcs)
 Table 53. Middle East & Africa Non-opioid Analgesic Patch Sales by Country (2020-2025) & (M Pcs)
 Table 54. Middle East & Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
 Table 55. Middle East & Africa Non-opioid Analgesic Patch Sales by Product (2020-2025) & (M Pcs)
 Table 56. Middle East & Africa Non-opioid Analgesic Patch Sales by Application (2020-2025) & (M Pcs)
 Table 57. Key Market Drivers & Growth Opportunities of Non-opioid Analgesic Patch
 Table 58. Key Market Challenges & Risks of Non-opioid Analgesic Patch
 Table 59. Key Industry Trends of Non-opioid Analgesic Patch
 Table 60. Non-opioid Analgesic Patch Raw Material
 Table 61. Key Suppliers of Raw Materials
 Table 62. Non-opioid Analgesic Patch Distributors List
 Table 63. Non-opioid Analgesic Patch Customer List
 Table 64. Global Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (M Pcs)
 Table 65. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 66. Americas Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (M Pcs)
 Table 67. Americas Non-opioid Analgesic Patch Annual Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 68. APAC Non-opioid Analgesic Patch Sales Forecast by Region (2026-2031) & (M Pcs)
 Table 69. APAC Non-opioid Analgesic Patch Annual Revenue Forecast by Region (2026-2031) & ($ millions)
 Table 70. Europe Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (M Pcs)
 Table 71. Europe Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 72. Middle East & Africa Non-opioid Analgesic Patch Sales Forecast by Country (2026-2031) & (M Pcs)
 Table 73. Middle East & Africa Non-opioid Analgesic Patch Revenue Forecast by Country (2026-2031) & ($ millions)
 Table 74. Global Non-opioid Analgesic Patch Sales Forecast by Product (2026-2031) & (M Pcs)
 Table 75. Global Non-opioid Analgesic Patch Revenue Forecast by Product (2026-2031) & ($ millions)
 Table 76. Global Non-opioid Analgesic Patch Sales Forecast by Application (2026-2031) & (M Pcs)
 Table 77. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2026-2031) & ($ millions)
 Table 78. Hisamitsu Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 79. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 80. Hisamitsu Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 81. Hisamitsu Pharmaceutical Main Business
 Table 82. Hisamitsu Pharmaceutical Latest Developments
 Table 83. Teikoku Seiyaku Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 84. Teikoku Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 85. Teikoku Seiyaku Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 86. Teikoku Seiyaku Main Business
 Table 87. Teikoku Seiyaku Latest Developments
 Table 88. IBSA Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 89. IBSA Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 90. IBSA Pharma Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 91. IBSA Pharma Main Business
 Table 92. IBSA Pharma Latest Developments
 Table 93. Kowa Company Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 94. Kowa Company Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 95. Kowa Company Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 96. Kowa Company Main Business
 Table 97. Kowa Company Latest Developments
 Table 98. Haleon Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 99. Haleon Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 100. Haleon Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 101. Haleon Main Business
 Table 102. Haleon Latest Developments
 Table 103. Kenvue Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 104. Kenvue Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 105. Kenvue Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 106. Kenvue Main Business
 Table 107. Kenvue Latest Developments
 Table 108. Opella Healthcare Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 109. Opella Healthcare Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 110. Opella Healthcare Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 111. Opella Healthcare Main Business
 Table 112. Opella Healthcare Latest Developments
 Table 113. Viatris Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 114. Viatris Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 115. Viatris Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 116. Viatris Main Business
 Table 117. Viatris Latest Developments
 Table 118. Teva Pharmaceuticals Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 119. Teva Pharmaceuticals Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 120. Teva Pharmaceuticals Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 121. Teva Pharmaceuticals Main Business
 Table 122. Teva Pharmaceuticals Latest Developments
 Table 123. Lead Chemical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 124. Lead Chemical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 125. Lead Chemical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 126. Lead Chemical Main Business
 Table 127. Lead Chemical Latest Developments
 Table 128. Mikasa Seiyaku Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 129. Mikasa Seiyaku Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 130. Mikasa Seiyaku Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 131. Mikasa Seiyaku Main Business
 Table 132. Mikasa Seiyaku Latest Developments
 Table 133. Averitas Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 134. Averitas Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 135. Averitas Pharma Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 136. Averitas Pharma Main Business
 Table 137. Averitas Pharma Latest Developments
 Table 138. Sparsha Pharma Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 139. Sparsha Pharma Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 140. Sparsha Pharma Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 141. Sparsha Pharma Main Business
 Table 142. Sparsha Pharma Latest Developments
 Table 143. TEH SENG Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 144. TEH SENG Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 145. TEH SENG Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 146. TEH SENG Pharmaceutical Main Business
 Table 147. TEH SENG Pharmaceutical Latest Developments
 Table 148. Anhui Fengyuan Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 149. Anhui Fengyuan Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 150. Anhui Fengyuan Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 151. Anhui Fengyuan Pharmaceutical Main Business
 Table 152. Anhui Fengyuan Pharmaceutical Latest Developments
 Table 153. Beijing Tide Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 154. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 155. Beijing Tide Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 156. Beijing Tide Pharmaceutical Main Business
 Table 157. Beijing Tide Pharmaceutical Latest Developments
 Table 158. Jiudian Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 159. Jiudian Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 160. Jiudian Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 161. Jiudian Pharmaceutical Main Business
 Table 162. Jiudian Pharmaceutical Latest Developments
 Table 163. Yunnan Baiyao Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 164. Yunnan Baiyao Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 165. Yunnan Baiyao Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 166. Yunnan Baiyao Main Business
 Table 167. Yunnan Baiyao Latest Developments
 Table 168. Lingrui Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 169. Lingrui Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 170. Lingrui Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 171. Lingrui Pharmaceutical Main Business
 Table 172. Lingrui Pharmaceutical Latest Developments
 Table 173. Anhui Jinma Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 174. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 175. Anhui Jinma Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 176. Anhui Jinma Pharmaceutical Main Business
 Table 177. Anhui Jinma Pharmaceutical Latest Developments
 Table 178. Guizhou Liansheng Pharmaceutical Basic Information, Non-opioid Analgesic Patch Manufacturing Base, Sales Area and Its Competitors
 Table 179. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Product Portfolios and Specifications
 Table 180. Guizhou Liansheng Pharmaceutical Non-opioid Analgesic Patch Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 181. Guizhou Liansheng Pharmaceutical Main Business
 Table 182. Guizhou Liansheng Pharmaceutical Latest Developments


List of Figures
 Figure 1. Picture of Non-opioid Analgesic Patch
 Figure 2. Non-opioid Analgesic Patch Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Non-opioid Analgesic Patch Sales Growth Rate 2020-2031 (M Pcs)
 Figure 7. Global Non-opioid Analgesic Patch Revenue Growth Rate 2020-2031 ($ millions)
 Figure 8. Non-opioid Analgesic Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
 Figure 9. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2024)
 Figure 10. Non-opioid Analgesic Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
 Figure 11. Product Picture of Lidocaine Patch
 Figure 12. Product Picture of Diclofenac Patch
 Figure 13. Product Picture of Methyl Salicylate Patch
 Figure 14. Product Picture of Flurbiprofen Patch
 Figure 15. Product Picture of Loxoprofen Sodium Patch
 Figure 16. Product Picture of Ketoprofen Patch
 Figure 17. Product Picture of Capsaicin Patch
 Figure 18. Product Picture of Others
 Figure 19. Global Non-opioid Analgesic Patch Sales Market Share by Product in 2025
 Figure 20. Global Non-opioid Analgesic Patch Revenue Market Share by Product (2020-2025)
 Figure 21. Non-opioid Analgesic Patch Consumed in Hospitals and Clinics
 Figure 22. Global Non-opioid Analgesic Patch Market: Hospitals and Clinics (2020-2025) & (M Pcs)
 Figure 23. Non-opioid Analgesic Patch Consumed in Retail Pharmacy
 Figure 24. Global Non-opioid Analgesic Patch Market: Retail Pharmacy (2020-2025) & (M Pcs)
 Figure 25. Non-opioid Analgesic Patch Consumed in Online Pharmacy
 Figure 26. Global Non-opioid Analgesic Patch Market: Online Pharmacy (2020-2025) & (M Pcs)
 Figure 27. Global Non-opioid Analgesic Patch Sale Market Share by Application (2024)
 Figure 28. Global Non-opioid Analgesic Patch Revenue Market Share by Application in 2025
 Figure 29. Non-opioid Analgesic Patch Sales by Company in 2025 (M Pcs)
 Figure 30. Global Non-opioid Analgesic Patch Sales Market Share by Company in 2025
 Figure 31. Non-opioid Analgesic Patch Revenue by Company in 2025 ($ millions)
 Figure 32. Global Non-opioid Analgesic Patch Revenue Market Share by Company in 2025
 Figure 33. Global Non-opioid Analgesic Patch Sales Market Share by Geographic Region (2020-2025)
 Figure 34. Global Non-opioid Analgesic Patch Revenue Market Share by Geographic Region in 2025
 Figure 35. Americas Non-opioid Analgesic Patch Sales 2020-2025 (M Pcs)
 Figure 36. Americas Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
 Figure 37. APAC Non-opioid Analgesic Patch Sales 2020-2025 (M Pcs)
 Figure 38. APAC Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
 Figure 39. Europe Non-opioid Analgesic Patch Sales 2020-2025 (M Pcs)
 Figure 40. Europe Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
 Figure 41. Middle East & Africa Non-opioid Analgesic Patch Sales 2020-2025 (M Pcs)
 Figure 42. Middle East & Africa Non-opioid Analgesic Patch Revenue 2020-2025 ($ millions)
 Figure 43. Americas Non-opioid Analgesic Patch Sales Market Share by Country in 2025
 Figure 44. Americas Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
 Figure 45. Americas Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
 Figure 46. Americas Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
 Figure 47. United States Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 48. Canada Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 49. Mexico Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 50. Brazil Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 51. APAC Non-opioid Analgesic Patch Sales Market Share by Region in 2025
 Figure 52. APAC Non-opioid Analgesic Patch Revenue Market Share by Region (2020-2025)
 Figure 53. APAC Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
 Figure 54. APAC Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
 Figure 55. China Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 56. Japan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 57. South Korea Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 58. Southeast Asia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 59. India Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 60. Australia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 61. China Taiwan Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 62. Europe Non-opioid Analgesic Patch Sales Market Share by Country in 2025
 Figure 63. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2020-2025)
 Figure 64. Europe Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
 Figure 65. Europe Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
 Figure 66. Germany Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 67. France Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 68. UK Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 69. Italy Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 70. Russia Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 71. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Country (2020-2025)
 Figure 72. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Product (2020-2025)
 Figure 73. Middle East & Africa Non-opioid Analgesic Patch Sales Market Share by Application (2020-2025)
 Figure 74. Egypt Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 75. South Africa Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 76. Israel Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 77. Turkey Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 78. GCC Countries Non-opioid Analgesic Patch Revenue Growth 2020-2025 ($ millions)
 Figure 79. Manufacturing Cost Structure Analysis of Non-opioid Analgesic Patch in 2025
 Figure 80. Manufacturing Process Analysis of Non-opioid Analgesic Patch
 Figure 81. Industry Chain Structure of Non-opioid Analgesic Patch
 Figure 82. Channels of Distribution
 Figure 83. Global Non-opioid Analgesic Patch Sales Market Forecast by Region (2026-2031)
 Figure 84. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2026-2031)
 Figure 85. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Product (2026-2031)
 Figure 86. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Product (2026-2031)
 Figure 87. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Application (2026-2031)
 Figure 88. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Application (2026-2031)

Companies Mentioned

Hisamitsu Pharmaceutical

Teikoku Seiyaku

IBSA Pharma

Kowa Company

Haleon

Kenvue

Opella Healthcare

Viatris

Teva Pharmaceuticals

Lead Chemical

Mikasa Seiyaku

Averitas Pharma

Sparsha Pharma

TEH SENG Pharmaceutical

Anhui Fengyuan Pharmaceutical

Beijing Tide Pharmaceutical

Jiudian Pharmaceutical

Yunnan Baiyao

Lingrui Pharmaceutical

Anhui Jinma Pharmaceutical

Guizhou Liansheng Pharmaceutical

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff